Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,396Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Accord healthcare

02 3Alembic Pharmaceuticals Limited

03 6Apotex Inc

04 3Astellas Pharma

05 3Aurobindo Pharma Limited

06 2Chartwell Pharmaceuticals llc

07 3Cipla Medpro South Africa

08 3Eurolab

09 6F. Hoffmann-La Roche

10 2Fujian South Pharmaceutical

11 5Hetero Drugs

12 3MSN Laboratories

13 3Natco Pharma

14 3Natco Pharma (Canada) Inc

15 2Nishchay Pharmaceuticals Pvt. Ltd.

16 2Pharmascience Inc.

17 3Rising Pharmaceuticals Inc

18 3Shilpa Medicare

19 3Sun Pharmaceutical Industries Limited

20 6Teva Pharmaceutical Industries

21 3Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2020-07-02

Application Number : 211083

Regulatory Info : DISCN

Registration Country : USA

blank

02

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2020-07-02

Application Number : 211083

Regulatory Info : DISCN

Registration Country : USA

blank

03

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2020-07-02

Application Number : 211083

Regulatory Info : DISCN

Registration Country : USA

blank

04

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 208396

Regulatory Info : DISCN

Registration Country : USA

blank

05

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 208396

Regulatory Info : DISCN

Registration Country : USA

blank

06

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 208396

Regulatory Info : DISCN

Registration Country : USA

blank

07

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : TARCEVA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2004-11-18

Application Number : 21743

Regulatory Info : DISCN

Registration Country : USA

blank

08

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : TARCEVA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2004-11-18

Application Number : 21743

Regulatory Info : DISCN

Registration Country : USA

blank

09

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : TARCEVA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2004-11-18

Application Number : 21743

Regulatory Info : DISCN

Registration Country : USA

blank

10

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2024-09-13

Application Number : 203843

Regulatory Info : RX

Registration Country : USA

blank

11

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2024-09-13

Application Number : 203843

Regulatory Info : RX

Registration Country : USA

blank

12

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2024-05-24

Application Number : 209267

Regulatory Info : RX

Registration Country : USA

blank

13

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2024-05-24

Application Number : 209267

Regulatory Info : RX

Registration Country : USA

blank

14

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2024-05-24

Application Number : 209267

Regulatory Info : RX

Registration Country : USA

blank

15

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 208488

Regulatory Info : DISCN

Registration Country : USA

blank

16

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 208488

Regulatory Info : RX

Registration Country : USA

blank

17

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 208488

Regulatory Info : DISCN

Registration Country : USA

blank

18

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2014-06-11

Application Number : 91002

Regulatory Info : RX

Registration Country : USA

blank

19

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2014-06-11

Application Number : 91002

Regulatory Info : RX

Registration Country : USA

blank

20

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2014-06-11

Application Number : 91002

Regulatory Info : RX

Registration Country : USA

blank

21

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 211960

Regulatory Info : RX

Registration Country : USA

blank

22

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 211960

Regulatory Info : RX

Registration Country : USA

blank

23

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 211960

Regulatory Info : RX

Registration Country : USA

blank

24

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 210300

Regulatory Info : DISCN

Registration Country : USA

blank

25

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 210300

Regulatory Info : DISCN

Registration Country : USA

blank

26

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2019-11-05

Application Number : 210300

Regulatory Info : DISCN

Registration Country : USA

blank

27

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2020-11-09

Application Number : 91059

Regulatory Info : RX

Registration Country : USA

blank

28

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2015-08-28

Application Number : 91059

Regulatory Info : RX

Registration Country : USA

blank

29

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2015-08-28

Application Number : 91059

Regulatory Info : RX

Registration Country : USA

blank

30

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ERLOTINIB HYDROCHLORIDE

Brand Name : ERLOTINIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2020-04-16

Application Number : 213065

Regulatory Info : RX

Registration Country : USA

blank